Charlie Hospital Semarang Tbk. vs Tigaraksa Satria Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Tigaraksa Satria Tbk. trades at Rp4,870 (market cap 4.47T, 100 24h volume). The key difference: Tigaraksa Satria Tbk. is far larger — about 6× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 100). Which is the better fit depends on your goals.
| RSCH | TGKA | |
|---|---|---|
Market Cap | 742B | 4.47T |
Volume | 29.45M | 100 |
Lot | 294.49K | 1 |
Turnover | 8.14B | 487K |
Average Price | 276.35 | 4,870 |
Value | 8.14B | 487K |
Indicative Equilibrium Price | 270 | — |
Indicative Equilibrium Volume | 103 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Tigaraksa Satria Tbk (the Company) was established in Jakarta based on notarial deed No. 35 of M.M.I. Wiardi, S.H., dated November 17, 1986. PT. Tigaraksa Satria is a distributor of Nutrition, Chemicals, Cosmetic, Books, Garments and other consumer goods. Founded in 1987 as a subsidiary of PT. Tigaraksa, the company handles the dosmetic distribution products for more than 20 pricipals.
Read more on TGKA →